Country Profile

Colombia

Colombia is a significant market for Indian pharmaceutical exports — $199M in FY 2025–26, with 3.3× growth over the past decade. Medicines accounts for 71% of shipments, with vaccines contributing $10.9M. The compound annual growth rate since FY2015 stands at 11.5%.

🇨🇴 $199M · 3.3× growth since FY2015 · 11.5% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$199M
Exports FY2025–26 DGCIS
3.3×
Growth FY2015→2026
11.5%
CAGR FY2015→2026
71%
Medicines Share
5
Product Categories Supplied
Colombia is a significant market for Indian pharmaceutical exports — $199M in FY 2025–26, with 3.3× growth over the past decade. Medicines accounts for 71% of shipments, with vaccines contributing $10.9M. The compound annual growth rate since FY2015 stands at 11.5%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $142M (71.4%) Medicine Ingredients $36.7M (18.5%) Vaccines $10.9M (5.5%) Surgical & Hospital Supplies $7.81M (3.9%) Traditional & Herbal $1.34M (0.7%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Colombia in the RBI overseas direct investment dataset (2011–2026).